Kansas City, Kan- The discussion focused on the use of lipoprotein apheresis to treat high cholesterol and preeclampsia.

Danielle Harp, who received apheresis for preeclampsia, shared her positive outcome, giving birth to a healthy baby at 37 weeks.

Dr. Marc Parrish and Dr. Patrick Moriarty emphasized the rarity of apheresis in the U.S. and its potential to improve pregnancy outcomes. They discussed ongoing studies to prove its safety and effectiveness in treating preeclampsia.

Danielle Harp, mother

• Danielle went through lipoprotein apheresis to treat her preeclampsia during pregnancy and now has a baby girl named Olivia Marie.
• She shares her final thoughts on the importance of advocating for one's health and the positive impact of lipoprotein apheresis on her life.

Dr. Marc Parrish, Maternal and Fetal medical Specialist, The University of Kansas Health System

• Dr. Parrish discusses the importance of awareness and early detection of preeclampsia to improve pregnancy outcomes.
• He discusses the potential for lipoprotein apheresis to become a more common treatment for preeclampsia and other cardiovascular conditions.

Dr. Patrick Moriarty, Director of Lipid-Apheresis Center, The University of Kansas Health System

• Dr. Moriarty discusses the potential benefits of lipoprotein apheresis in treating preeclampsia and improving pregnancy outcomes.
• He highlights ongoing research and studies to prove the safety and effectiveness of lipoprotein apheresis in pregnancy.

Friday, May 23rd is the next Morning Medical Update

Kidney Transplant between Mother and Son- Born with a rare condition called 'prune belly' syndrome, he faced impossible odds—until his mother gave him the ultimate gift: a life-saving organ transplant. Now thriving in grade school, his journey is a powerful testament to love, resilience, and the life-changing impact of organ donation.